290 related articles for article (PubMed ID: 28681334)
21. Permeation studies of novel terbinafine formulations containing hydrophobins through human nails in vitro.
Vejnovic I; Huonder C; Betz G
Int J Pharm; 2010 Sep; 397(1-2):67-76. PubMed ID: 20620203
[TBL] [Abstract][Full Text] [Related]
22. Iontophoretic terbinafine HCL 1.0% delivery across porcine and human nails.
Amichai B; Mosckovitz R; Trau H; Sholto O; Ben-Yaakov S; Royz M; Barak D; Nitzan B; Shemer A
Mycopathologia; 2010 May; 169(5):343-9. PubMed ID: 20012894
[TBL] [Abstract][Full Text] [Related]
23. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement.
Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F
Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051
[TBL] [Abstract][Full Text] [Related]
24. Application of central composite design for the optimization of itraconazole loaded nail lacquer formulation.
Rahman A; Aqil M; Ahad A; Imam SS; Qadir A; Ali A
3 Biotech; 2021 Jul; 11(7):324. PubMed ID: 34194908
[TBL] [Abstract][Full Text] [Related]
25. Antifungal Nail Lacquer for Enhanced Transungual Delivery of Econazole Nitrate.
Puri V; Savla R; Chen K; Robinson K; Virani A; Michniak-Kohn B
Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297639
[TBL] [Abstract][Full Text] [Related]
26. Design and development of a safer non-invasive transungual drug delivery system for topical treatment of onychomycosis.
Pal P; Thakur RS; Ray S; Mazumder B
Drug Dev Ind Pharm; 2015; 41(7):1095-9. PubMed ID: 24980914
[TBL] [Abstract][Full Text] [Related]
27. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
Elsayed MM
J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and tolerability of amorolfine 5% nail lacquer in combination with systemic antifungal agents for onychomycosis: A meta-analysis and systematic review.
Feng X; Xiong X; Ran Y
Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28097731
[TBL] [Abstract][Full Text] [Related]
29. Formulation design and optimization of cationic-charged liposomes of brimonidine tartrate for effective ocular drug delivery by design of experiment (DoE) approach.
Soni PK; Saini TR
Drug Dev Ind Pharm; 2021 Nov; 47(11):1847-1866. PubMed ID: 35484943
[TBL] [Abstract][Full Text] [Related]
30. Matrix based system of isotretinoin as nail lacquer to enhance transungal delivery across human nail plate.
Joshi M; Sharma V; Pathak K
Int J Pharm; 2015 Jan; 478(1):268-277. PubMed ID: 25445993
[TBL] [Abstract][Full Text] [Related]
31. Effect of a novel penetration enhancer on the ungual permeation of two antifungal agents.
Traynor MJ; Turner RB; Evans CR; Khengar RH; Jones SA; Brown MB
J Pharm Pharmacol; 2010 Jun; 62(6):730-7. PubMed ID: 20636860
[TBL] [Abstract][Full Text] [Related]
32. A Novel Apremilast Nail Lacquer Formulation for the Treatment of Nail Psoriasis.
Kushwaha AS; Repka MA; Narasimha Murthy S
AAPS PharmSciTech; 2017 Nov; 18(8):2949-2956. PubMed ID: 28455829
[TBL] [Abstract][Full Text] [Related]
33. Luliconazole Nail Lacquer for the Treatment of Onychomycosis: Formulation, Characterization and In Vitro and Ex Vivo Evaluation.
Dehari D; Mehata AK; Priya V; Parbat D; Kumar D; Srivastava AK; Singh S; Agrawal AK
AAPS PharmSciTech; 2022 Jun; 23(6):175. PubMed ID: 35750993
[TBL] [Abstract][Full Text] [Related]
34. Chemical avulsion with urea nail lacquer.
Baran R; Tosti A
J Dermatolog Treat; 2002 Dec; 13(4):161-4. PubMed ID: 19753735
[TBL] [Abstract][Full Text] [Related]
35. Linalool-Incorporated Synergistically Engineered Modified Liposomal Nanocarriers for Enhanced Transungual Delivery of Terbinafine against Onychomycosis.
Gupta I; Adin SN; Rashid MA; Alhamhoom Y; Aqil M; Mujeeb M
Materials (Basel); 2023 Jun; 16(12):. PubMed ID: 37374607
[TBL] [Abstract][Full Text] [Related]
36. Determination of the efficacy of terbinafine hydrochloride nail solution in the topical treatment of dermatophytosis in a guinea pig model.
Ghannoum MA; Long L; Pfister WR
Mycoses; 2009 Jan; 52(1):35-43. PubMed ID: 18498299
[TBL] [Abstract][Full Text] [Related]
37. Validation of bovine hoof slices as a model for infected human toenails: in vitro ciclopirox transungual permeation.
Monti D; Saccomani L; Chetoni P; Burgalassi S; Tampucci S; Mailland F
Br J Dermatol; 2011 Jul; 165(1):99-105. PubMed ID: 21410668
[TBL] [Abstract][Full Text] [Related]
38. Formulation, characterization and ex vivo studies of terbinafine HCl liposomes for cutaneous delivery.
Sudhakar B; Varma JN; Murthy KV
Curr Drug Deliv; 2014; 11(4):521-30. PubMed ID: 24410098
[TBL] [Abstract][Full Text] [Related]
39. Onychomycosis due to Neoscytalidium treated with oral terbinafine, ciclopirox nail lacquer and nail abrasion: a pilot study of 25 patients.
Cursi ÍB; Silva RT; Succi IB; Bernardes-Engemann AR; Orofino-Costa R
Mycopathologia; 2013 Feb; 175(1-2):75-82. PubMed ID: 22976905
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.
Auvinen T; Tiihonen R; Soini M; Wangel M; Sipponen A; Jokinen JJ
Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
